Frequently Asked Questions
Glenmark Pharmaceuticals maintains strict quality standards and has obtained certifications such as ISO 9001, ISO 14001, and ISO 27001. The company complies with Good Manufacturing Practices (GMP) and other regulatory guidelines in the countries where it operates.
Yes, Glenmark Pharmaceuticals has ventured into the development and manufacturing of biosimilars, which are similar versions of biologic drugs. These biosimilars are used to treat conditions such as cancer, autoimmune diseases, and chronic inflammatory disorders.
Yes, Glenmark Pharmaceuticals has a strong global presence. It operates in more than 80 countries, with subsidiaries, representative offices, and manufacturing facilities worldwide. The company exports its products to various markets across Asia, Europe, Africa, and the Americas.
Yes, Glenmark Pharmaceuticals has a dedicated research and development division focused on discovering and developing innovative medicines. The company invests in cutting-edge research to address unmet medical needs and improve patient care.
Glenmark Pharmaceuticals has manufacturing facilities in multiple locations, including India, the United States, Switzerland, Brazil, and Argentina. These facilities adhere to strict quality standards and comply with regulatory guidelines.